Why has the Sigma (ASX:SIG) share price dived 14% so far in December?

What’s happened to Sigma shares?

| More on:
a man in business attire plunges into a room filled with water with bubbles streaming along his body as though he has completed a high dive.

Image source: Getty Images

The Sigma Healthcare Ltd (ASX: SIG) share price has had a disappointing month, falling by more than 14% so far. This comes after the pharmacy chain operator and distributor provided investors with a trading update earlier in December.

At the time of writing, Sigma shares are going nowhere, trading flat at 43 cents a pop.

What’s driving Sigma shares lower?

Over the last few weeks, investors have sold off Sigma shares following the company’s admission of a difficult trading year.

On 6 December, Sigma released a trading update to the ASX advising a downgraded earnings guidance for FY22.

The company noted that earnings before interest, tax, depreciation and amortisation (EBITDA) will be 10% lower compared to FY21. In contrast, Sigma previously stated in September that EBIDTA is forecasted for a 5% growth.

The company acknowledged that it has been impacted by shorter-term operational issues as well as COVID-19. The former relates to the roll-out of its Enterprise Resource Planning (ERP), with Sigma switching to the live SAP environment.

The combination of these factors resulted in an unexpected increase in operating costs through the transition. One-off and non-operating costs are expected to come around at $25 million to $30 million.

Investors drew ire of the trading update, sending the Sigma share price 7.62% lower on the day. However, the selling didn’t stop there, with its shares continuing to slide another 10% over the next two days.

The Sigma share price has been yet to recover from the heavy selling, hitting a record low of 42.5 cents yesterday.

While still months away, investors may want to pencil in the company’s FY22 results on 29 March 2022.

About the Sigma share price

Over the last 12 months, Sigma shares have traversed mostly sideways with a few hiccups along the way. Its shares are down 30% over the period, including year-to-date.

Based on today’s price, Sigma presides a market capitalisation of roughly $460.79 million, with over 1.06 billion shares outstanding.

Should you invest $1,000 in Sigma right now?

Before you consider Sigma, you'll want to hear this.

Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now... and Sigma wasn't one of them.

The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.

*Returns as of January 13th 2022

The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Healthcare Shares

Nothing to see here, just a storm in a teacup as far as this boy and girl are concerned, sipping tea in their living room.
Healthcare Shares

‘Storm in a teacup’: Why the Imugene share price is lifting 14% today

What did Imugene reveal in its letter to shareholders today?

Read more »

A man flies into the sky over a city building-scape with a rocket jet pack sketched onto his back representing the Imugene share price skyrocketing today
Healthcare Shares

Imugene share price surges 18% to lead the ASX 200 on Thursday

What's behind the meteoric gain for this ASX 200 healthcare stock today?

Read more »

Rising arrow on a blue graph symbolising a rising share price.
Healthcare Shares

Next Science shares defy ASX market slump to surge 8%

Next Science shares are set to finish Thursday's trading session on a high note.

Read more »

Team celebrating corporate success screaming with joy.
Healthcare Shares

How is the Polynovo share price managing to push higher today?

Polynovo shares are defying the broader ASX market on Thursday.

Read more »

An unhappy man in a suit sits at his desk with his arms crossed staring the his laptop screen as the Mesoblast share price falls
Healthcare Shares

Mesoblast share price dips amid latest class action news

The company is being taken to court by another unhappy shareholder.

Read more »

A smiling woman looks at her computer laptop in her home with warm lights in the background feeling happy to see the EMvision share price rising
Healthcare Shares

EMvision share price rockets 11% on $5 million pay day

Shares in the Australian medical device company shot higher today.

Read more »

retirement investing represented by older investor looking concerned at computer screen
Healthcare Shares

Why is the Medibank share price struggling to gain ground in May?

We check what's going on with shares in the private health insurer.

Read more »

Person pointing at an increasing blue graph which represents a rising share price.
Healthcare Shares

Here’s why the Imugene share price just got a boost

Imugene's latest announcement is rallying up investors.

Read more »